Brief: Jeil Pharmaceutical to divest medicine business into new unit
Sept 8 (Reuters) - Jeil Pharmaceutical Co Ltd 002620.KS :
* Says to divest medicine business into a new wholly owned
subsidiary, namely Jeil Health Science Inc
* Says division effective date of Nov. 1 and registration
date of Nov. 1
Source text in Korean: http://goo.gl/gRYzyR
Further company Coverage: 002620.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +861062674724;
Reuters Messaging: lima.jin.reuters.com@reuters.net))
Recent news on Jeil Pharma Holdings
See all newsBrief: Jeil Pharma Holdings to raise 377.12 bln won via private placement
Brief: Jeil Pharma Holdings to buy properties for 46.3 bln won
Brief: Jeil Pharmaceutical says annual cash dividend for FY 2016
Brief: Jeil Pharmaceutical to divest medicine production business into new subsidiary
Brief: Jeil Pharmaceutical to divest medicine business into new unit